Pfizer-BioNTech COVID-19 vaccine approved for children ages 12 to 15

By: Alyssa Wilson

The Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine to be used in children as young as 12 on an emergency use basis.  

Acting FDA Commissioner Dr. Janet Woodwock said the decision by the organization can get the United States closer to a return to normal and that they took the review seriously, CNBC reported.  

A clinical trial involving more than 2,000 12-to-15-year-olds revealed that the vaccine was well tolerated. It had an efficacy rate of 100% within the age group.  

RELATED: Pfizer, BioNTech COVID-19 vaccine 100% effective in children 12 – 15  

On Wednesday, the CDC endorsed the safety and effectiveness of the Pfizer-BioNTech vaccine for the age group. 

RELATED: Pfizer, BioNTech testing COVID-19 vaccine in children under 12 

Pfizer and BioNTech also began testing the vaccine on children between the ages of 6 months and 11 years old.  

Latest in News


Highlighting the Importance of Investing and Retirement


Black Woman SCOTUS Justice ‘Long Overdue,’ Biden Says 


NJ Supreme Court Tosses Robbery Convictions, Cites Bias in Police Stop 

David Conners Sues Walmart


Black Officer Sues Walmart for ‘Racially Charged’ Shoplifter Error


Georgia Pastor, Wife Arrested After 8 Found Locked In Basement  


Customization and Health Collide With Black-Owned Brand PersonaliTEA


Child Abuse Report: Deaths of Black Children Up During COVID-19 Pandemic 


Lawsuit: Wyoming’s 1st Black Sheriff Aaron Appelhans Fires Racist Deputy